Cargando…

Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice

Nasal administration has emerged as a promising and attractive route for vaccination, especially for the prophylaxis of respiratory diseases. Our previous studies have shown that severe acute respiratory syndrome coronavirus (SARS-CoV) virus-like particles (VLPs) can be assembled using a recombinant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Baojing, Huang, Yi, Huang, Li, Li, Bao, Zheng, Zhenhua, Chen, Ze, Chen, Jianjun, Hu, Qinxue, Wang, Hanzhong
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Science Inc 2010
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878469/ https://www.ncbi.nlm.nih.gov/pubmed/20406307 http://dx.doi.org/10.1111/j.1365-2567.2010.03231.x

Ejemplares similares

Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice
por: Lu, Xinya, et al.
Publicado: (2007)

Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses
por: Bai, Bingke, et al.
Publicado: (2008)

Virus-Like Particles of SARS-Like Coronavirus Formed by Membrane Proteins from Different Origins Demonstrate Stimulating Activity in Human Dendritic Cells
por: Bai, Bingke, et al.
Publicado: (2008)

Assembly of human severe acute respiratory syndrome coronavirus-like particles
por: Ho, Yu, et al.
Publicado: (2004)

Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV
por: Lokugamage, Kumari G., et al.
Publicado: (2008)

Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity
por: Mi, Youjun, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Pets in Wuhan, China
por: Chen, Jianjun, et al.
Publicado: (2020)

Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques
por: Liu, L, et al.
Publicado: (2016)

Expression of the Severe Acute Respiratory Syndrome Coronavirus 3a Protein and the Assembly of Coronavirus-Like Particles in the Baculovirus Expression System
por: Khan, Sehaam, et al.
Publicado: (2007)

Functional Severe Acute Respiratory Syndrome Coronavirus 2 Virus-Like Particles From Insect Cells
por: Naskalska, Antonina, et al.
Publicado: (2021)

Delayed Antiviral Immune Responses in Severe Acute Respiratory Syndrome Coronavirus Infected Pregnant Mice
por: Zhu, Guohua, et al.
Publicado: (2022)

Intranasally inoculated bacterium-like particles displaying porcine epidemic diarrhea virus S1 protein induced intestinal mucosal immune response in mice
por: Su, Kai, et al.
Publicado: (2023)

Virus-Like Particles-Based Mucosal Nanovaccines
por: Rosales-Mendoza, Sergio, et al.
Publicado: (2019)

Novel coronavirus-like particles targeting cells lining the respiratory tract
por: Naskalska, Antonina, et al.
Publicado: (2018)

Enhanced Mucosal Immune Responses to HIV Virus-Like Particles Containing a Membrane-Anchored Adjuvant
por: Vassilieva, Elena V., et al.
Publicado: (2011)

Mucosal and Systemic Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Determined by Severity of Primary Infection
por: Sajadi, Mohammad M., et al.
Publicado: (2022)

Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Jia, Lijia, et al.
Publicado: (2021)

Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19
por: Zheng, Bin, et al.
Publicado: (2021)

Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase
por: Fan, Keqiang, et al.
Publicado: (2004)

Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus
por: Devaraj, Santhana G., et al.
Publicado: (2007)

Recovery Infectious Enterovirus 71 by Bac-to-Bac Expression System in vitro and in vivo
por: Lu, Baojing, et al.
Publicado: (2022)

Update on neurological symptoms in patients infected with severe acute respiratory syndrome coronavirus‐2
por: Xiao, Mei‐Fang, et al.
Publicado: (2021)

A Single Mutation in the VP1 Gene of Enterovirus 71 Enhances Viral Binding to Heparan Sulfate and Impairs Viral Pathogenicity in Mice
por: Ke, Xianliang, et al.
Publicado: (2020)

Characteristics and roles of severe acute respiratory syndrome coronavirus 2‐specific antibodies in patients with different severities of coronavirus 19
por: Huang, Z., et al.
Publicado: (2020)

A Novel Bacterium-Like Particle Vaccine Displaying the MERS-CoV Receptor-Binding Domain Induces Specific Mucosal and Systemic Immune Responses in Mice
por: Li, Entao, et al.
Publicado: (2019)

Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus
por: Chou, Chi-Yuan, et al.
Publicado: (2008)

Human Bocavirus NS1 and NS1-70 Proteins Inhibit TNF-α-Mediated Activation of NF-κB by targeting p65
por: Liu, Qingshi, et al.
Publicado: (2016)

Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles
por: Kumar, Binod, et al.
Publicado: (2021)

CORONAVIRUS-LIKE PARTICLES IN DIARRHOEA STOOLS
por: Caul, E.O., et al.
Publicado: (1980)

CORONAVIRUS-LIKE PARTICLES IN DIARRHOEA STOOLS
por: Curry, A., et al.
Publicado: (1980)

Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus
por: Lan, Jiaming, et al.
Publicado: (2018)

Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus
por: Deng, Yao, et al.
Publicado: (2018)

Combined Interventions for Severe Novel Coronavirus Disease (COVID-19): Experience from 350 Patients
por: Guo, Ting, et al.
Publicado: (2020)

Mucosal immunity: an overview and studies of enteric and respiratory coronavirus infections in a swine model of enteric disease
por: Saif, Linda J.
Publicado: (1996)

Common Respiratory Viruses and Pulmonary Mucosal Immunology
por: Huang, David B.
Publicado: (2006)

Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2
por: Chen, Yeh, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus nucleocapsid protein confers ability to efficiently produce virus-like particles when substituted for the human immunodeficiency virus nucleocapsid domain
por: Wang, Shui-Mei, et al.
Publicado: (2008)

Maturation Mechanism of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-like Proteinase
por: Li, Chunmei, et al.
Publicado: (2010)

Boosting Vaccine-Elicited Respiratory Mucosal and Systemic COVID-19 Immunity in Mice With the Oral Lactobacillus plantarum
por: Xu, Jianqing, et al.
Publicado: (2021)

Coronavirus-like particles in nonhuman primate feces
por: Smith, G. C., et al.
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_326a3bh9e61r4qtlfsqkl5f481